Atlas Trials

Drug-Drug Interaction Between PK101-001 and PK101-002

Clinical trial NCT03553316 · COMPLETED

Trial details

NCT number
NCT03553316
Sponsor
PMG Pharm Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Arthritis
Start date
2019-02-28
Primary completion
2019-03-22
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.